PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 244.00
0.00 (0.00%)
Sep 2, 2026, 1:56 PM WIB
IDX:DGNS Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 335,500 | 230,000 | 243,750 | 307,500 | 305,000 | 931,250 | |
Market Cap Growth | 89.01% | -5.64% | -20.73% | 0.82% | -67.25% | - |
Enterprise Value | 390,359 | 303,274 | 294,051 | 321,534 | 278,689 | 897,615 |
Last Close Price | 244.00 | 184.00 | 195.00 | 246.00 | 244.00 | 745.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 157.21 | 78.31 | 326.11 | - | 24.08 | 14.48 |
PS Ratio | 1.90 | 1.38 | 1.50 | 2.11 | 1.58 | 3.08 |
PB Ratio | 1.46 | 1.13 | 1.24 | 1.57 | 1.45 | 4.62 |
P/TBV Ratio | 1.48 | 1.14 | 1.25 | 1.58 | 1.45 | 4.62 |
P/FCF Ratio | 79.97 | 88.99 | - | - | - | - |
P/OCF Ratio | 38.69 | 21.58 | 8.93 | 23.32 | - | 15.82 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.21 | 1.82 | 1.80 | 2.21 | 1.45 | 2.97 |
EV/EBITDA Ratio | 24.79 | 20.34 | 21.48 | - | 10.52 | 10.41 |
EV/EBIT Ratio | 69.43 | 49.48 | 152.83 | - | 16.30 | 11.02 |
EV/FCF Ratio | 93.05 | 117.33 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.32 | 0.38 | 0.36 | 0.28 | 0.06 | 0.03 |
Debt / EBITDA Ratio | 4.64 | 4.50 | 4.26 | - | 0.44 | 0.06 |
Debt / FCF Ratio | 17.42 | 29.85 | - | - | - | - |
Net Debt / Equity Ratio | 0.24 | 0.33 | 0.33 | 0.22 | -0.08 | -0.23 |
Net Debt / EBITDA Ratio | 3.94 | 4.51 | 4.76 | -11.87 | -0.65 | -0.53 |
Net Debt / FCF Ratio | 13.08 | 26.00 | -4.05 | -1.70 | 0.43 | 5.13 |
Asset Turnover | 0.55 | 0.54 | 0.57 | 0.57 | 0.80 | 1.61 |
Inventory Turnover | 18.97 | 15.89 | 17.87 | 14.76 | 13.84 | 22.64 |
Quick Ratio | 3.01 | 2.41 | 2.50 | 3.96 | 7.63 | 4.70 |
Current Ratio | 4.72 | 3.30 | 3.64 | 6.08 | 11.28 | 5.78 |
Return on Equity (ROE) | 0.96% | 1.47% | 0.38% | -6.73% | 6.14% | 42.74% |
Return on Assets (ROA) | 1.09% | 1.24% | 0.42% | -3.70% | 4.44% | 27.18% |
Return on Invested Capital (ROIC) | 0.91% | 1.25% | 0.67% | -7.02% | 7.16% | 52.19% |
Return on Capital Employed (ROCE) | 1.80% | 2.10% | 0.70% | -5.90% | 7.50% | 37.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.61% | 1.28% | 0.31% | -4.44% | 4.15% | 6.91% |
FCF Yield | 1.25% | 1.12% | -6.60% | -8.18% | -13.13% | -0.96% |
Payout Ratio | - | - | - | - | - | 9.33% |
Buyback Yield / Dilution | -5.00% | - | - | - | -0.78% | -24.04% |